Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Published in Diabetes

News · July 06, 2023

ADA 2023: Tirzepatide Results in Significant Weight Loss in Patients With Obesity, Type 2 Diabetes

Participants lost up to 15 percent of their body weight after 72 weeks

PracticeUpdate Editorial Team

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Sign in

Not a member?

Join for free

featured

Cardiac Insulin Resistance in Individuals With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis

Diabetes Care · December 06, 2023

updated
featured

Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes

N. Engl. J. Med · December 06, 2023

updated
featured

Diagnostic Accuracy and Feasibility of Noninvasive Prenatal Testing

Diabetologia · December 06, 2023

updated
featured

Semaglutide for Weight Loss in Patients With Severe Obesity With or Without a History of Bariatric Surgery

Obesity · December 06, 2023

updated
featured

The Fusion Clinic: Establishment and Initial Diabetes Outcomes

Diabet. Med. · December 06, 2023
featured

Associations of Early Pregnancy Serum Uric Acid Levels With the Risk of Gestational Diabetes and Birth Outcomes

BMC Endocr Disord · December 06, 2023
featured

Impact of Insulin Independence Following Islet Transplantation on Long-Term Metabolic Outcomes

Diabet. Med. · December 05, 2023
featured

Relationship of Alcohol Consumption With Type 2 Diabetes Based on BMI

Diabetes Care · December 04, 2023
story of the week

HbA1c Levels Impact the Effect of a Lifestyle Intervention on the Risk for Cardiovascular Events

J. Clin. Endocrinol. Metab. · November 30, 2023
featured

Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Patients With Type 2 Diabetes

Diabetes Care · November 30, 2023
featured

Challenges in Identifying and Studying Type 1 Diabetes in Adults

Diabetologia · November 29, 2023

ADA 2023: Tirzepatide Results in Significant Weight Loss in Patients With Obesity, Type 2 Diabetes

Further Reading

Cardiac Insulin Resistance in Individuals With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis

Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes

Diagnostic Accuracy and Feasibility of Noninvasive Prenatal Testing

Semaglutide for Weight Loss in Patients With Severe Obesity With or Without a History of Bariatric Surgery

The Fusion Clinic: Establishment and Initial Diabetes Outcomes

Associations of Early Pregnancy Serum Uric Acid Levels With the Risk of Gestational Diabetes and Birth Outcomes

Impact of Insulin Independence Following Islet Transplantation on Long-Term Metabolic Outcomes

Relationship of Alcohol Consumption With Type 2 Diabetes Based on BMI

HbA1c Levels Impact the Effect of a Lifestyle Intervention on the Risk for Cardiovascular Events

Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Patients With Type 2 Diabetes

Challenges in Identifying and Studying Type 1 Diabetes in Adults

Recently Updated